Depth estimation of protoporphyrin IX objects in turbid media considering the fluorescence intensity ratio between two wavelengths of light for application in invasion diagnosis of gastric cancer

Optical Review - This paper demonstrates a method to estimate the depth of a fluorescence object in turbid media using dual-wavelength excited photodynamic diagnosis, to aid in the invasion depth...     

PEO-based composite lithium polymer electrolyte, PEO-BaTiO3-Li(C2F5SO2)2N

Polyethylene oxide (PEO) based polymer electrolytes with BaTiO₃ as filler and Li(C₂F₅SO₂)₂N as salt have been examined in lithium polymer batteries. The aluminum disolution potential in PEO-Li(C₂F₅SO₂)₂N was estimated to be 4.1 V vs. Li/Li⁺ at 80 °C, which was compared to that of 3.8 V vs. Li/Li⁺ in PEO-Li(CF₃SO₂)₂N. The electrical conductivity of the system was measured as a function of O/Li ratio. The highest conductivity was observed in O/Li=8. The conductivity was 1.65×10⁻³ S/cm at 80 °C and 1.5×10⁻⁵ S/cm at 25 °C. The interfacial resistance of Li/polymer electrolyte/Li annealed at 80 °C for 15 days was lower than 100 Ωcm². Paper presented at the 8th EuroConference on Ionics, Carvoeiro, Algarve, Portugal, Sept. 16 – 22, 2001.     

Novel method to control release of lipophilic drugs with high potency from silicone

Silicone has been utilized as a carrier material for sustained release system of lipophilic drugs. Extensive studies revealed that drug release rate is influenced by factors such as physicochemical properties of the drug and additives.(1-5)) When a lipophilic drug is highly potent at low concentrations, the drug release rate should be strictly controlled so as to avoid side effects. In this study, using vitamin D(3) (VD(3)) as an example of such drugs, we investigated novel method to suppress initial burst and to modify drug release rate from silicone matrix. As a result, it was found that (a). addition of human serum albumin (HSA) suppressed initial burst and enhanced release rate in the later stage, resulting constant release of VD(3), (b). covering a matrix formulation with a membrane of low diffusivity (core-rod formulation) suppressed initial burst and released drug in a constant rate, and (3) using materials for which the drug has high affinity as dissolution solvent (reservoir formulation), the drug release rate was reduced.     

Structural researches on the chelating behaviour of the biguanide ligand. The crystal structures of Co(C2H6N5)3 · 2H2O and Cu(C2H7N5)2CO3·4H20

Summary Crystals of the title compounds are both monoclinic, with unit cell dimensions:a = 9.293(5),b = 10.122(5),c = 16.737(7) Å. = 103.44(3)°,Z = 4, space groupP2₁/c for the cobalt derivative;a = 13.1ß5(7),b = 17.546(ß),c = 6.871(3) Å, = 107.01(4)°Z = 4, space groupP2₁/n for the copper derivative. The structures were solved from diffractometer data by the heavy-atom technique for the first compound and by direct methods for the second compound. Refinement by block diagonal least-squares gaveR = 5.9% for 3511 independent reflections andR = 8.8% for 2885 independent reflections for the cobalt and copper compound respectively. In both compounds the biguanide moiety behaves as a bidentate chelating ligand in a symmetrical tautomeric form, but it is deprotonated in the octahedral cobalt compound and neutral in the square planar copper compound.     

Synthesis,characterization and a thermogravimetric study of copper,cobalt and tin mono- and bis-adducts with ethyleneurea,ethylenethiourea and propyleneurea

This paper describes the synthesis, characterization and a thermogravimetric (t.g.) study of 11 adducts of general formula MCl₂·nL (M = Cu, Co and Sn; n = 1 and 2 for Sn, and 2 for Cu and Co; L = ethyleneurea eu, ethylenethiourea etu, and propyleneurea pu). The i.r. results shows that the eu and pu adducts are coordinated through oxygen, whereas for etu nitrogen is the coordination site. The (C=O) or (C=S) trend is: Cu > Co > Sn. The t.g. curves show that the adducts release ligand molecules in a single mass loss step. As regards considering adducts with the same stoichiometry, the observed thermal stability trend is: etu > pu > eu.     

1,6-dihydro-3(2H)-pyridinones as synthetic intermediates. Total synthesis of (±)-tecomanine

The first and stereoselective total synthesis of (±)-tecomanine ($\text{1}$) has been achieved from ethyl 1,6-dihydro-3(2H)-pyridinone-1-carboxylate ($\text{2}$) as a synthon.     

Photochemical valence tautomerization of berberinephenolbetaines to 8,14-cycloberbines,versatile aziridine derivatives for spirobenzylisoquinolines

Irradiation of the berberinephenolbetaines ($\text{8}$$\text{a}$, $\text{8}$$\text{b}$, and $\text{8}$$\text{c}$) effected valence tautomerization to give the 8,14-cycloberbines ($\text{9}$$\text{a}$, $\text{9}$$\text{b}$, and $\text{9}$$\text{c}$), the aziridine derivatives, in high yield. The 8,14-cycloberbines were efficiently converted to the spirobenzylisoquinolines by regioselective C bond cleavage.     

Chiral HPLC Separation of Rosiglitazone and its Main Metabolites and Studies on Their Racemization

Rosiglitazone (RSG) is marketed as a racemic mixture although the antidiabetic activity is essentially related to the (S)-enantiomer. The chiral center has an adjacent carbonyl group; therefore, the (R)-enantiomer could be transformed to the (S)-enantiomer or vice versa by keto-enolic tautomerism. The literature indicates that this racemization is slow enough to allow the evaluation of the properties of the isolated enantiomers. However, there is no information about the enantioselective kinetic disposition and metabolism of RSG. Additionally, there are no studies on the racemization of its metabolites. Considering these facts, a chiral HPLC method was developed and used for the first time to study the racemization of RSG and its main metabolites. Different conditions, including those used to evaluate the in vitro enantioselective metabolism, were employed. The simultaneous chiral separation of RSG and metabolites was achieved on a Chiralcel OJ-H column by employing methanol/ethanol (90:10, v/v) as mobile phase. The racemization studies showed that the half-life of RSG decreased more than 30 times when the temperature increased from 4 to 37 °C. It was also observed that the half-life of RSG changed from approximately 20 h at pH 3.5 to approximately 2 h at pH 7.4. The same profile was observed for its metabolites. Organic solvents and UV light did not present influence on the racemization process. In addition, a Complete Factorial Design was conducted to evaluate the influence of some parameters that can be changed during an in vitro metabolism study. The results obtained showed that the racemization occurs under in vitro metabolism conditions.